
CAXTON CORP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | CMPX | 29K | $158.39K |
![]() | IKT | 28K | $58.33K |
![]() | KYTX | 19K | $176.47K |
![]() | CNTX | 18K | $27.05K |
![]() | MNMD | 16K | $210.06K |
![]() | XFOR | 16K | $62.23K |
![]() | LXEO | 14K | $138.45K |
![]() | SABS | 11K | $39.37K |
![]() | SYRE | 9K | $292.19K |
![]() | BRK-B | 710 | $356.77K |

Compass Therapeutics, Inc.
CMPX
Shares Held
29K
Value
$158.39K

Inhibikase Therapeutics, Inc.
IKT
Shares Held
28K
Value
$58.33K

Kyverna Therapeutics, Inc.
KYTX
Shares Held
19K
Value
$176.47K

Context Therapeutics Inc.
CNTX
Shares Held
18K
Value
$27.05K

Mind Medicine (MindMed) Inc.
MNMD
Shares Held
16K
Value
$210.06K

X4 Pharmaceuticals, Inc.
XFOR
Shares Held
16K
Value
$62.23K

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
14K
Value
$138.45K

SAB Biotherapeutics, Inc.
SABS
Shares Held
11K
Value
$39.37K

Spyre Therapeutics, Inc.
SYRE
Shares Held
9K
Value
$292.19K

Berkshire Hathaway Inc.
BRK-B
Shares Held
710
Value
$356.77K
